Dynamic Technology Lab Private Ltd raised its position in shares of Bruker Corp. (NASDAQ:BRKR) by 15.6% during the second quarter, Holdings Channel reports. The firm owned 20,651 shares of the company’s stock after buying an additional 2,789 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Bruker Corp. were worth $469,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp boosted its position in Bruker Corp. by 27.2% in the first quarter. State Street Corp now owns 1,527,696 shares of the company’s stock valued at $42,770,000 after buying an additional 326,527 shares during the period. Quantitative Investment Management LLC boosted its position in Bruker Corp. by 157.7% in the second quarter. Quantitative Investment Management LLC now owns 63,900 shares of the company’s stock valued at $1,453,000 after buying an additional 39,100 shares during the period. BlackRock Inc. boosted its position in Bruker Corp. by 118.8% in the first quarter. BlackRock Inc. now owns 13,454 shares of the company’s stock valued at $377,000 after buying an additional 7,305 shares during the period. BlackRock Group LTD boosted its position in Bruker Corp. by 6.4% in the first quarter. BlackRock Group LTD now owns 101,843 shares of the company’s stock valued at $2,851,000 after buying an additional 6,123 shares during the period. Finally, BlueMountain Capital Management LLC purchased a new position in Bruker Corp. during the first quarter valued at approximately $932,000. Hedge funds and other institutional investors own 70.04% of the company’s stock.

Bruker Corp. (NASDAQ:BRKR) opened at 22.33 on Tuesday. The firm’s 50-day moving average is $22.32 and its 200-day moving average is $25.37. Bruker Corp. has a 12 month low of $15.78 and a 12 month high of $29.85. The stock has a market cap of $3.60 billion, a P/E ratio of 33.63 and a beta of 0.91.

Bruker Corp. (NASDAQ:BRKR) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $0.20 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.20. The company had revenue of $371.70 million for the quarter, compared to analyst estimates of $409.57 million. Bruker Corp. had a net margin of 6.86% and a return on equity of 22.66%. The business’s quarterly revenue was down 6.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.19 earnings per share. On average, equities analysts forecast that Bruker Corp. will post $1.00 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 23rd. Stockholders of record on Tuesday, September 6th will be paid a dividend of $0.04 per share. The ex-dividend date is Thursday, September 1st. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.73%. Bruker Corp.’s dividend payout ratio is currently 24.24%.

Several research analysts have commented on BRKR shares. Zacks Investment Research cut shares of Bruker Corp. from a “buy” rating to a “hold” rating in a report on Tuesday, July 5th. Jefferies Group reiterated a “buy” rating on shares of Bruker Corp. in a report on Friday, June 10th. Barclays PLC lowered their price target on shares of Bruker Corp. from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Wednesday, August 3rd. Cleveland Research cut shares of Bruker Corp. from a “buy” rating to a “neutral” rating in a report on Friday, July 22nd. Finally, Deutsche Bank AG started coverage on shares of Bruker Corp. in a report on Wednesday, June 1st. They set a “hold” rating for the company. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Bruker Corp. currently has a consensus rating of “Hold” and a consensus target price of $25.80.

In other news, Director Richard A. Packer acquired 10,000 shares of the company’s stock in a transaction dated Wednesday, August 10th. The shares were bought at an average price of $21.97 per share, for a total transaction of $219,700.00. Following the completion of the purchase, the director now directly owns 22,500 shares of the company’s stock, valued at approximately $494,325. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Frank H. Laukien acquired 4,500 shares of the company’s stock in a transaction dated Friday, August 5th. The shares were purchased at an average price of $22.17 per share, for a total transaction of $99,765.00. Following the purchase, the chief executive officer now directly owns 37,658,733 shares of the company’s stock, valued at $834,894,110.61. The disclosure for this purchase can be found here. Insiders own 35.80% of the company’s stock.

About Bruker Corp.

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

5 Day Chart for NASDAQ:BRKR

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corp. (NASDAQ:BRKR).

Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.